about
Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interactionTarget therapy in metastatic pheochromocytoma: current perspectives and controversiesThe HILDA complex coordinates a conditional switch in the 3'-untranslated region of the VEGFA mRNAClinical update on cancer: molecular oncology of head and neck cancerVariants of SCARB1 and VDR Involved in Complex Genetic Interactions May Be Implicated in the Genetic Susceptibility to Clear Cell Renal Cell CarcinomaHypoxia-mediated autophagic flux inhibits silver nanoparticle-triggered apoptosis in human lung cancer cells.Nek1 phosphorylates Von Hippel-Lindau tumor suppressor to promote its proteasomal degradation and ciliary destabilization.Expression of hypoxia-inducible factor 3α in hepatocellular carcinoma and its association with other hypoxia-inducible factorsLoss of PIG3 increases HIF-1α level by promoting protein synthesis via mTOR pathway in renal cell carcinoma cells.Sirt1 regulates glial progenitor proliferation and regeneration in white matter after neonatal brain injury.Changing paradigms in the treatment of malignant pheochromocytoma.Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.IGF-1R Promotes Symmetric Self-Renewal and Migration of Alkaline Phosphatase+ Germ Stem Cells through HIF-2α-OCT4/CXCR4 Loop under Hypoxia.Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma.Lactate influences the gene expression profile of human mesenchymal stem cells (hMSC) in a dose dependant manner.Expression and significance of HIF-1α and HIF-2α in pancreatic cancer.Low tumor glutathione level as a sensitivity marker for glutamate-cysteine ligase inhibitors.
P2860
Q27674057-A2205910-5E6C-4386-9F15-B4358E588113Q28087343-F51267B8-3E56-4FFB-ACEB-CE5E7C60CA76Q28535448-FFFC1A6D-253F-4B15-A87B-9AADD39D7BE1Q33695197-04B11976-BCB6-46BD-8E07-2214F42C9078Q35475660-00E66D80-C8E1-4A03-B44E-29757ED9A351Q36574369-FDC340A2-38BF-4A3D-97D9-BEA0963C7C76Q36604618-EC3CFC65-D43C-44A0-85AB-111CBABD1DA9Q36953993-80487F94-46C5-4F1E-87AE-AA697BEAF515Q37317201-8621DF62-D4ED-42EB-9E93-3EF70232CDCEQ37533313-9F6C73DE-E879-4895-A979-994BFD3C331AQ37859612-EC278C0E-C6B9-431F-93A1-B9606EF5051CQ38663615-3EB7A0DD-5F11-46FA-B180-0C6161855E33Q40495238-FE4ACA44-5385-4B24-8009-2BA7F3156D62Q45350842-4D70910C-27B4-4673-9CE5-083E740D1273Q47226479-B10771F2-9FE4-44DC-B5E6-8BB6CB024DAEQ51082266-05AF7001-AFCA-44AF-9976-7A61FBFC42D1Q51535014-3FD882B7-D673-453F-AD07-E30BD3F6A98EQ53243450-1E117E34-A314-4B6E-AA32-9285CCFE6A6EQ55164552-F219453D-5531-4542-82CE-43FCC78435CA
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The VHL tumor suppressor: master regulator of HIF
@ast
The VHL tumor suppressor: master regulator of HIF
@en
The VHL tumor suppressor: master regulator of HIF
@nl
type
label
The VHL tumor suppressor: master regulator of HIF
@ast
The VHL tumor suppressor: master regulator of HIF
@en
The VHL tumor suppressor: master regulator of HIF
@nl
prefLabel
The VHL tumor suppressor: master regulator of HIF
@ast
The VHL tumor suppressor: master regulator of HIF
@en
The VHL tumor suppressor: master regulator of HIF
@nl
P2860
P3181
P1476
The VHL tumor suppressor: master regulator of HIF
@en
P2860
P304
P3181
P356
10.2174/138161209789649394
P407
P577
2009-01-01T00:00:00Z